Neurological manifestations of congenital Zika virus infection
- 754 Downloads
In 2015, it was observed a rise in the number of microcephalic newborns associated with a history of non-specific febrile sickness and rash during pregnancy in Brazil. Since then, microcephaly has emerged as a public health concern. A few months after, the causal relation between congenital microcephaly and the Zika virus was discovered. Zika virus, an arbovirus, is a new TORCH member that leads to congenital infection through vertical transmission and harms the developing brain, disrupting synaptogenesis, and causing other central nervous system lesions.
The purpose of this article is to report the congenital Zika syndrome (CZS) and to emphasize the need for follow-up of the affected children to better know the evolutionary history of this new agent and to optimize the provision of healthcare and improve the quality of life of these patients.
We review the most relevant literature about clinical manifestations and neuroimaging findings related to neurotropism of Zika virus to characterize the congenital Zika syndrome and suggest the systematization of some exams and procedures to evaluate children exposed to ZIKV with or without microcephaly, according to the author’s own experience.
Vertical ZIKV infection can cause a wide spectrum of neurological manifestations that go beyond microcephaly, and even the non-microcephalic child should be followed during the first years of life, because infection may be asymptomatic or lead to neuropsicomotor delay, epilepsy, and visual abnormalities. The appropriate prospective multidisciplinary follow-up of these patients aims to understand the natural history of this new agent and to provide a better development and quality of life for them and their families.
KeywordsZika virus Congenital Zika virus syndrome Microcephaly Neurological manifestations
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Brazilian Ministry of Health Surveillance and response protocol to the occurrence of microcephaly and/or central nervous system (CNS) abnormalities [in Portuguese]. http://combateaedes.saude.gov.br/images/sala-de-situacao/Microcefalia-Protocolo-de-vigilancia-e-resposta-10mar2016-18h.pdf
- 5.Manuguerra J-C, Despres P, Fournier E, Mallet H-P, Musso D, Fontanet* A, Neil* J, Ghawché F, Pan American Health Organization, Washington, DC (2016) Zika virus and the Guillain–Barré syndrome—case series from seven countries. N Engl J Med 375:1598–1601. https://doi.org/10.1056/NEJMc1609015 CrossRefGoogle Scholar
- 6.Aumento de Síndrome de Guillain Barré e anomalias congênitas em áreas com zika leva OPAS/OMS a enviar atualização epidemiológica. http://www.paho.org/bra/index.php
- 7.European Centre for Disease Prevention and Control (2014) Rapid risk assessment: Zika virus infection outbreak, French Polynesia. ECDC, Stockholm. 14 Feb 2014Google Scholar
- 10.Brasil MdSd (2015) Situação epidemiológica de ocorrência de microcefalias no Brasil, 2015. Boletim Epidemiológico 46:1–3Google Scholar
- 11.Brasil P, Pereira JP Jr, Raja Gabaglia C, Damasceno L, Wakimoto M, Ribeiro Nogueira RM et al (2016) Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa1602412
- 12.Martines RB, Bhatnagar J, Keating MK, Silva-Flannery L, Muehlenbachs A, Gary J et al (2016) Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep 65:159–160. 10.15585/mmwr.mm6506e1 CrossRefPubMedGoogle Scholar
- 15.WHO (2016) Zika situation report. Neurological syndrome and congenital abnormalities. http://www.who.int/mediacentre/news/statements/2016/emergency-committee-zika-microcephaly/en/
- 16.Moore CM, Staples JE, Dobyns WB, Pessoa A, Ventura CV, da Fonseca EB, et al (2016) Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr 2016:E1–E8. https://doi.org/10.1001/jamapediatrics.2016.3982
- 17.WHO Screening, assessment and management of neonates and infants with complications associated with Zika virus exposure in útero. Rapid Advice Guideline 30 August 2016 WHO/ZIKV/MOC/16.3/Rev3Google Scholar
- 23.Moura da Silva AA, Ganz JSS, Sousa PS, Doriqui MJR, Ribeiro MRC, Britto e Alves MTSS et al (2016) Early Growth and Neurologic outcomes of Infants with Probable Congenital Zika Virus Syndrome. Emerg Infect Dis 22(11):1953–1956. https://doi.org/10.3201/eid2211.160956 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Brasil MdSd (2017) Orientações integradas de vigilância e atenção à saúde no âmbito da Emergência de Saúde Pública de Importância Nacional: procedimentos para o monitoramento das alterações no crescimento e desenvolvimento a partir da gestação até a primeira infância, relacionadas à infecção pelo vírus Zika e outras etiologias infeciosas dentro da capacidade operacional do SUS [recurso eletrônico] / Ministério da Saúde, Secretaria de Vigilância em Saúde, Secretaria de Atenção à Saúde. – Brasília: Ministério da Saúde. http://portalarquivos.saude.gov.br/images/pdf/2016/dezembro/12/orientacoes-integradas-vigilancia-atencao.pdf
- 26.Bayley Scales of infant and Toddler development (Bayley-III). Pearson Education, Inc. San Antonio ,TX. www.pearsonassess.com/